Jordi Ribas-Maynou

Dr. Jordi Ribas-Maynou

Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2013 in Andrology
Verified
Journal Article
Open access
PDF file
JRJordi Ribas-Maynou
Jordi Ribas-Maynou
AGA. García-Peiró
A. García-Peiró
AFA. Fernández-Encinas
A. Fernández-Encinas
CAC. Abad
C. Abad
MAM. J. Amengual
M. J. Amengual
JBJordi Benet
Jordi Benet
Sperm DNA fragmentation (SDF) is becoming an important test to assess male infertility. Several different tests are available, but no consensus has yet been reached as to which tests are most predictive of infertility. Few publications have reported a comprehensive analysis comparing these methods within the same population. The objective of this study was to analyze the differences between the five most common methodologies, to study their correlations and to establish their cut‐off values, sensitivity and specificity in predicting male infertility. We found differences in SDF between fertile donors and infertile patients in TUNEL, SCSA, SCD and alkaline Comet assays, but none with the neutral Comet assay. The alkaline COMET assay was the best in predicting male infertility followed by TUNEL, SCD and SCSA, whereas the neutral COMET assay had no predictive power. For our patient population, threshold values for infertility were 20.05% for TUNEL assay, 18.90% for SCSA, 22.75% for the SCD test, 45.37% for alkaline Comet and 34.37% for neutral Comet. This work establishes in a comprehensive study that the all techniques except neutral Comet are useful to distinguish fertile and infertile men.

1 March 2021 in Biological Reviews
Verified
Journal Article
Closed access
PDF file
JRJordi Ribas-Maynou
Jordi Ribas-Maynou
Marc YesteMarc Yeste
Marc Yeste
NBNerea Becerra‐Tomás
Nerea Becerra‐Tomás
KAKenneth I. Aston
Kenneth I. Aston
EJEmma R. James
Emma R. James
Albert Salas-HuetosAlbert Salas-Huetos
Albert Salas-Huetos

31 January 2019 in Genes
Verified
Journal Article
Open access
PDF file
JRJordi Ribas-Maynou
Jordi Ribas-Maynou
JBJordi Benet
Jordi Benet
Reproductive diseases have become a growing worldwide problem and male factor plays an important role in the reproductive diagnosis, prognosis and design of assisted reproductive treatments. Sperm cell holds the mission of carrying the paternal genetic complement to the oocyte in order to contribute to an euploid zygote with proper DNA integrity. Sperm DNA fragmentation had been used for decades as a male fertility test, however, its usefulness have arisen multiple debates, especially around Intracytoplasmic Sperm Injection (ICSI) treatments. In the recent years, it has been described that different types of sperm DNA breaks (single and double strand DNA breaks) cause different clinical reproductive effects. On one hand, single-strand DNA breaks are present extensively as a multiple break points in all regions of the genome, are related to oxidative stress and cause a lack of clinical pregnancy or an increase of the conception time. On the other hand, double-strand DNA breaks are mainly localized and attached to the sperm nuclear matrix as a very few break points, are possibly related to a lack of DNA repair in meiosis and cause a higher risk of miscarriage, low embryo quality and higher risk of implantation failure in ICSI cycles. The present work also reviews different studies that may contribute in the understanding of sperm chromatin as well as treatments to prevent sperm DNA damage.

1 April 2019 in Fertility and Sterility
Verified
Journal Article
Closed access
ACAida Casanovas
Aida Casanovas
JRJordi Ribas-Maynou
Jordi Ribas-Maynou
SLSandra Lara-Cerrillo
Sandra Lara-Cerrillo
AJAna Raquel Jimenez-Macedo
Ana Raquel Jimenez-Macedo
OHOlga Hortal
Olga Hortal
AGAgustín García-Peiró
Agustín García-Peiró

17 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JRJordi Ribas-Maynou
Jordi Ribas-Maynou
AGAgustín García-Peiró
Agustín García-Peiró
AFAlba Fernandez-Encinas
Alba Fernandez-Encinas
MAMaria José Amengual
Maria José Amengual
EPElena Prada
Elena Prada
JBJordi Benet
Jordi Benet
It is known that sperm samples from recurrent pregnancy loss (RPL) couples have an increase in their sperm DNA fragmentation (SDF), but no studies have been performed in order to identify differences between single stranded SDF (ssSDF) and double stranded SDF (dsSDF) in these patients. This could be relevant because the type of DNA damage could have different effects. Semen samples were classified attending their clinical status: 25 fertile donors and 20 RPL patients with at least two unexplained first trimester miscarriages. SDF was analysed using alkaline and neutral Comet assay, SCD test and pulsed-field gel electrophoresis (PFGE), and ROC analysis including data from 105 more infertile patients (n = 150) was performed to establish predictive threshold values. SDF for alkaline and neutral Comet, and the SCD test was analysed in these categories of individuals. Data revealed the presence of two subgroups within fertile donors. The values obtained were 21.10±9.13, 23.35±10.45 and 12.31±4.31, respectively, for fertile donors with low values for both ssSDF and dsSDF; 27.86±12.64, 80.69±12.67 and 12.43±5.22, for fertile donors with low ssSDF and high dsSDF; and 33.61±15.50, 84.64±11.28 and 19.28±6.05, for unexplained RPL patients, also showing a low ssSDF and high dsSDF profile. This latter profile was seen in 85% of unexplained RPL and 33% of fertile donors, suggesting that it may be associated to a male risk factor for undergoing RPL. ROC analysis regarding recurrent miscarriage set the cut-off value at 77.50% of dsDNA SDF. PFGE for low ssSDF and high dsSDF profile samples and positive controls treated with DNase, to induce dsDNA breaks, showed a more intense band of about 48 kb, which fits the toroid model of DNA compaction in sperm, pointing out that some nuclease activity may be affecting their sperm DNA in RPL patients. This work identifies a very specific SDF profile related to the paternal risk of having RPL.

19 June 2015 in Human Fertility
Verified
Journal Article
Closed access
JGJosep Gual-Frau
Josep Gual-Frau
CACarlos Abad
Carlos Abad
MAMaría J. Amengual
María J. Amengual
NHNaim Hannaoui
Naim Hannaoui
MCMiguel A. Checa
Miguel A. Checa
JPJuan Prats
Juan Prats
Infertile males with varicocele have the highest percentage of sperm cells with damaged DNA, compared to other infertile groups. Antioxidant treatment is known to enhance the integrity of sperm DNA; however, there are no data on the effects in varicocele patients. We thus investigated the potential benefits of antioxidant treatment specifically in grade I varicocele males. Twenty infertile patients with grade I varicocele were given multivitamins (1500 mg L-Carnitine, 60 mg vitamin C, 20 mg coenzyme Q10, 10 mg vitamin E, 200 μg vitamin B9, 1 μg vitamin B12, 10 mg zinc, 50 μg selenium) daily for three months. Semen parameters including total sperm count, concentration, progressive motility, vitality, and morphology were determined before and after treatment. In addition, sperm DNA fragmentation and the amount of highly degraded sperm cells were analyzed by Sperm Chromatin Dispersion. After treatment, patients showed an average relative reduction of 22.1% in sperm DNA fragmentation (p = 0.02) and had 31.3% fewer highly degraded sperm cells (p = 0.07). Total numbers of sperm cells were increased (p = 0.04), but other semen parameters were unaffected. These data suggest that sperm DNA integrity in grade I varicocele patients may be improved by oral antioxidant treatment.